L. Chai et al. / Tetrahedron Letters 47 (2006) 9283–9285
9285
Acknowledgement
10. Han, B.; Liu, Z.-G.; Liu, Q.; Yang, L.; Liu, Z.-L.; Yu, W.
Tetrahedron 2006, 62, 2492.
1
1. (a) Takabata, E.; Kodama, R.; Tanaka, Y.; Dohmori, R.;
The authors thank Gannan Normal University for
financial support.
Tachizawa, H.; Naito, T. Chem. Pharm. Bull. 1979, 16,
1
900; (b) Parmar, S. S.; Pandey, B. R.; Dwivedi, C.;
Harbison, R. D. J. Pharm. Sci. 1974, 63, 1152.
2. Dodwadmath, R. P.; Wheeler, T. S. Proc. Ind. Acad. Sci.
1935, 2A, 438.
3. Smith, L. I.; Howard, K. L. J. Am. Chem. Soc. 1943, 65,
159.
14. Auwers, K.; Heimke, P. Liebigs Ann. 1927, 458, 186.
15. Bhatnagar, I.; George, M. V. Tetrahedron 1968, 24, 1293.
16. Gladstone, W. A. F.; Norman, R. O. C. J. Chem. Soc.,
Chem. Commun. 1966, 1536.
1
1
References and notes
1
. (a) Gilchrist, T. L. Heterocyclic Chemistry, 3rd ed.;
Addison-Wesley Longman: England, 1998; (b) Lednicer,
D. Strategies for Organic Drugs Synthesis and Design;
Wiley and Sons: New York, 1998, Chapters 8 and 9.
. (a) Stout, D. M.; Meyers, A. I. Chem. Rev. 1982, 82, 223;
2
3
4
(
2
b) Bocker, R. H.; Guengerich, F. P. J. Med. Chem. 1986,
8, 1596.
17. Singh, S. P.; Kumar, D.; Prakash, O.; Kapoor, R. P.
Synth. Commun. 1997, 27, 2683.
18. (a) Ueno, T.; Shiraishi, H.; Iwayanagi, T.; Nonogaki, S. J.
Electrochem. Soc. 1985, 132, 1168; (b) Nicolaou, K. C.;
Montagnon, T.; Baran, P. S. Angew. Chem., Int. Ed. 2002,
41, 1386.
. Guengerich, F. P.; Brian, W. R.; Iwasaki, M.; Sari, M. A.;
Baarhielm, C.; Berntsson, P. J. Med. Chem. 1991, 34,
1
. (a) Sausins, A.; Duburs, G. Heterocycles 1988, 27, 291; (b)
Chennot, T.; Eisner, U. J. Chem. Soc., Perkin Trans. 1
1
838.
19. Typical procedure: the starting materials were put into
water, and 20 mol % I O or 20 mol % I O /5 mol % KBr
975, 926; (c) Vanden Eynde, J.-J.; D’Orazio, R.; Van
2
5
2
5
Haverbeke, Y. Tetrahedron 1994, 50, 2479; (d) Pfister, J.
R. Synthesis 1990, 689; (e) Yadav, J. S.; Subba Reddy, B.
V.; Sabitha, G.; Kiran Kumar Reddy, G. S. Synthesis
were added in potions, detected by TLC, when completed,
abstracted by ethyl acetate, washed by Na SO , dried with
2
3
anhydrous MgSO , isolated through column chromato-
4
2
000, 11, 1532; (f) Mao, Y.-Z.; Jin, M.-Z.; Liu, Z.-L.; Wu,
graphy. Characteristic identify of representative products:
0
L.-M. Org. Lett. 2000, 2, 741; (g) Zhang, D.; Wu, L.-Z.;
Zhou, L.; Han, X.; Yang, Q.-Z.; Zhang, L.-P.; Tung,
C.-H. J. Am. Chem. Soc. 2004, 126, 3440.
. Arguello, J.; Nunez-Vergara, L. J.; Sturm, J. C.; Squella, J.
A. Electrochim. Acta 2004, 49, 4849.
compounds 1 a: diethyl 4-(4-chlorophenyl)-2,6-dimethyl-
4
e
3,5-pyridinedicarboxylate, pale yellow solid; mp 65–
1
66 °C; H NMR (300 MHz, CDCl ): d = 0.95 (t, 6H,
3
5
6
7
8
9
J = 7.2 Hz), 2.59 (s, 6H), 4.02 (q, 4H, J = 7.2 Hz), 7.18 (d,
2H, J = 8.4 Hz), 7.34 (d, 2H, J = 8.4 Hz); C NMR
1
3
. Nakamichi, N.; Kawashita, Y.; Hayashi, M. Org. Lett.
(75 MHz, CDCl ): d = 13.5, 22.8, 61.4, 126.7, 128.2, 129.5,
3
2
002, 4, 3955.
. Mashraqui, S. H.; Karnik, M. A. Tetrahedron Lett. 1998,
9, 4895.
. Nakamichi, N.; Kawashita, Y.; Hayashi, M. Synthesis
004, 1015.
134.6, 134.9, 144.7, 155.5, 167.5; EI-MS: m/z = 363, 361,
0
316, 288, 270, 139, 43. Compound 2 a: 1,3,5-triphenyl-
1
0 1
3
pyrazole: H NMR (300 MHz, CDCl ): d = 6.83 (s, 1H),
3
13
7.4 (m, 13H), 7.92 (d, 2H, J = 7.6Hz); C NMR (75 MHz,
2
CDCl ): d = 105.2, 125.3, 125.8, 127.4, 128.0, 128.3, 128.4,
3
. Heravi, M. M.; Behbahani, F. K.; Oskooie, H. A.; Shoar,
128.6, 128.7, 128.9, 130.5, 133.0, 140.0, 144.3, 151.9; EI-
R. H. Tetrahedron Lett. 2005, 46, 2775.
MS: m/z = 296, 86, 84, 77.